Sphera Global Health Care and Medison were among the participants in a round that took Orchard Therapeutics’ overall funding past $290m.
Author: Robert Lavine
Sarepta intercepts Lacerta for $30m investment
Gene therapy developer Lacerta Therapeutics has secured funding from Sarepta Therapeutics as part of a licensing agreement.
Capsule delivers $50m series B
Online pharmacist Capsule has taken new funding, just over a year after its Virgin-backed series A round.
Dynamic Yield brings in $32m
Union Tech Ventures took part in the series D round, which increased the personalised marketing software provider’s total funding to $77m.
Millendo overtakes OvaScience in merger deal
Roche and AstraZeneca-backed endocrine disease therapy developer Millendo will merge with publicly-listed OvaScience, raising a further $30m in the process.
ZipGo buses in Essel for series B round
Essel Group has invested $43.7m in ZipGo through its Essel Green Mobility subsidiary that will fund the expansion of its bus service.
Nio starts engine on $1.8bn IPO
The smart electric vehicle producer, whose largest investor is Tencent, was valued at $5bn as of late last year and has filed to go public in the US.
JD.com joins efforts to raise $5.8bn fund
The e-commerce firm has joined Sequoia Capital China and the state-owned China Reform Holdings for a late-stage fund with a $5.8bn target.
GLP sends series A funding to Wangjiahuan
Fresh produce distributor Wangjiahuan has raised $58.5m from Global Logistic Properties subsidiary Hidden Hill Modern Logistics Private Equity Fund.
SenseTime scouts Li for investment role
Jennifer Xuan Li has moved from an investment position at Baidu to a similar post at SenseTime, which is becoming increasingly active in corporate venturing.
Ambys shows ambition with $60m series A
Takeda invested $20m in the round and is providing $80m in development financing through a strategic partnership deal.
Domino dots the i’s on $40m round
Domino Data Lab has now raised more than $81m altogether, having received $40m in a round co-led by Sequoia Capital and Coatue Management.
SGE finds PerkSpot with $50m investment
12-year old employee benefits platform PerkSpot raised its first external funding, securing $50m from Susquehanna Growth Equity.
Boston Scientific spikes Veniti in $108m acquisition
Boston Scientific, which paid $25m for a 25% stake in the venous stent developer two years ago, has agreed to buy the company in full.